Bank of Montreal Can Reduces Position in Henry Schein, Inc. (NASDAQ:HSIC)

Bank of Montreal Can lowered its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 79.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 145,690 shares of the company's stock after selling 565,797 shares during the period. Bank of Montreal Can owned 0.12% of Henry Schein worth $10,082,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also bought and sold shares of HSIC. MML Investors Services LLC raised its stake in shares of Henry Schein by 5.1% during the 3rd quarter. MML Investors Services LLC now owns 11,000 shares of the company's stock worth $802,000 after acquiring an additional 535 shares in the last quarter. Nomura Asset Management Co. Ltd. boosted its position in shares of Henry Schein by 1.0% in the 3rd quarter. Nomura Asset Management Co. Ltd. now owns 38,816 shares of the company's stock worth $2,830,000 after purchasing an additional 373 shares in the last quarter. Barclays PLC grew its stake in Henry Schein by 6.9% during the 3rd quarter. Barclays PLC now owns 286,475 shares of the company's stock worth $20,882,000 after buying an additional 18,458 shares during the last quarter. M&T Bank Corp increased its position in Henry Schein by 4.5% during the 3rd quarter. M&T Bank Corp now owns 10,990 shares of the company's stock valued at $802,000 after buying an additional 472 shares in the last quarter. Finally, Toronto Dominion Bank raised its stake in Henry Schein by 68.3% in the third quarter. Toronto Dominion Bank now owns 62,779 shares of the company's stock valued at $4,577,000 after buying an additional 25,474 shares during the last quarter. Institutional investors own 96.62% of the company's stock.

Insider Activity

In other Henry Schein news, Director Philip A. Laskawy sold 2,604 shares of the stock in a transaction on Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total transaction of $184,988.16. Following the transaction, the director now directly owns 24,805 shares of the company's stock, valued at $1,762,147.20. This trade represents a 9.50 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Bradford C. Connett sold 4,036 shares of Henry Schein stock in a transaction dated Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total transaction of $287,161.40. Following the completion of the sale, the chief executive officer now owns 62,688 shares in the company, valued at approximately $4,460,251.20. This trade represents a 6.05 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.14% of the company's stock.

Henry Schein Stock Performance

HSIC traded up $1.44 during midday trading on Friday, hitting $64.73. 1,390,004 shares of the company were exchanged, compared to its average volume of 1,610,124. The firm has a market capitalization of $7.93 billion, a price-to-earnings ratio of 26.64, a price-to-earnings-growth ratio of 2.13 and a beta of 0.84. The company's 50 day simple moving average is $70.67 and its 200 day simple moving average is $72.01. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. Henry Schein, Inc. has a 1-year low of $60.56 and a 1-year high of $82.49.

Henry Schein (NASDAQ:HSIC - Get Free Report) last released its quarterly earnings data on Tuesday, February 25th. The company reported $1.19 EPS for the quarter, missing the consensus estimate of $1.23 by ($0.04). The company had revenue of $3.19 billion during the quarter, compared to analysts' expectations of $3.25 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The company's revenue for the quarter was up 5.8% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.66 EPS. As a group, sell-side analysts predict that Henry Schein, Inc. will post 4.74 earnings per share for the current year.

Wall Street Analysts Forecast Growth

HSIC has been the topic of several recent analyst reports. Barrington Research restated an "outperform" rating and set a $90.00 price objective on shares of Henry Schein in a report on Wednesday, February 26th. Bank of America upgraded shares of Henry Schein from an "underperform" rating to a "buy" rating and upped their price target for the company from $69.00 to $84.00 in a research note on Monday, January 6th. Wells Fargo & Company initiated coverage on shares of Henry Schein in a report on Friday, February 14th. They issued an "equal weight" rating and a $80.00 price target for the company. Jefferies Financial Group boosted their price objective on shares of Henry Schein from $77.00 to $80.00 and gave the company a "hold" rating in a report on Thursday, January 23rd. Finally, StockNews.com lowered Henry Schein from a "buy" rating to a "hold" rating in a research note on Thursday. Six analysts have rated the stock with a hold rating, five have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $81.10.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.